1. Home
  2. XHR vs GHRS Comparison

XHR vs GHRS Comparison

Compare XHR & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenia Hotels & Resorts Inc.

XHR

Xenia Hotels & Resorts Inc.

HOLD

Current Price

$19.06

Market Cap

1.6B

Sector

Real Estate

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

BUY

Current Price

$29.81

Market Cap

1.8B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
XHR
GHRS
Founded
2007
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
XHR
GHRS
Price
$19.06
$29.81
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$15.67
$41.38
AVG Volume (30 Days)
691.4K
316.8K
Earning Date
05-01-2026
05-01-2026
Dividend Yield
3.48%
N/A
EPS Growth
326.67
N/A
EPS
N/A
N/A
Revenue
$1,078,500,000.00
N/A
Revenue This Year
$3.94
N/A
Revenue Next Year
$2.68
N/A
P/E Ratio
$95.81
N/A
Revenue Growth
3.80
N/A
52 Week Low
$11.75
$11.83
52 Week High
$22.06
$31.44

Technical Indicators

Market Signals
Indicator
XHR
GHRS
Relative Strength Index (RSI) 37.44 56.74
Support Level $14.11 $25.66
Resistance Level $20.83 $31.22
Average True Range (ATR) 0.55 1.43
MACD -0.22 -0.12
Stochastic Oscillator 9.74 54.46

Price Performance

Historical Comparison
XHR
GHRS

About XHR Xenia Hotels & Resorts Inc.

Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other regions. Xenia's revenue is divided between the sale of rooms, food and beverages, and other sources.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: